isoproterenol has been researched along with enalaprilat anhydrous in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fontan, M; Gallo, A; Gomez Llambi, H; Mazzadi, A; Taquini, AC; Taquini, CM | 1 |
Antonangelo, L; Capellozzi, V; Ferreira, C; Luna Filho, B; Murad, N; Póvoa, R | 1 |
Costa, EA; Ferreira Filho, C; Ferreira, C; Ferreira, M; Luna Filho, B; Murad, N; Póvoa, R | 1 |
Giammattei, CE; Rose, JC; Strandhoy, JW | 1 |
Adameova, A; Boknik, P; Doka, G; Kirchhefer, U; Klimas, J; Kmecova, J; Krenek, P; Kruzliak, P; Kucerova, D; Kyselovic, J; Matus, M; Mueller, FU; Turcekova, K | 1 |
1 review(s) available for isoproterenol and enalaprilat anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for isoproterenol and enalaprilat anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effect of enalaprilic acid on cardiac contractile response to beta-adrenergic stimulation.
Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Dose-Response Relationship, Drug; Enalaprilat; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Rats; Rats, Inbred Strains | 1990 |
[Left ventricular hypertrophy--its reversion speeded up by enalaprilat].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotonic Agents; Drug Evaluation, Preclinical; Enalaprilat; Heart; Hypertrophy, Left Ventricular; Isoproterenol; Male; Myocardium; Nucleolus Organizer Region; Rats; Rats, Wistar | 1997 |
[Enalaprilat in the prevention of left ventricular hypertrophy induced by isoproterenol].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Enalaprilat; Hypertrophy, Left Ventricular; Isoproterenol; Male; Myocardium; Rats; Rats, Wistar | 1997 |
Regulation of in vitro renin secretion by ANG II feedback manipulation in vivo in the ovine fetus.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Embryonic and Fetal Development; Enalaprilat; Enzyme Precursors; Feedback; Fetus; Gestational Age; In Vitro Techniques; Isoproterenol; Juxtaglomerular Apparatus; Kidney; Renin; Sheep | 1999 |
Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Blotting, Western; Calcium Channels, L-Type; Cell Separation; Electrolytes; Enalaprilat; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Organ Size; Potassium Channels; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ultrasonography; Up-Regulation | 2015 |